Document resource
In this paper by Singh and colleagues (BMJ 2026;393:e085716, doi:10.1136/bmj-2025-085716, published 9 April 2026), the supplementary materials have been updated.
Annotated abstract
Correction: Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial)
bmj · 2026-04-21 · canonical JSON source